The antitumor efficiency and clinical translation of traditional nanomedicines is mainly
restricted by low drug loading, complex preparation technology, and potential toxicity …

Lipid–drug conjugates (LDCs) are drug molecules that have been covalently modified with
lipids. The conjugation of lipids to drug molecules increases lipophilicity and also changes …

The present work highlights recent achievements in development of nanostructured
dispersions and biocolloids for drug delivery applications. We emphasize the key role of …

Colorectal cancer (CRC) is the third most frequently occurring tumor in the human
population. CRCs are usually adenocarcinomatous and originate as a polyp on the inner …

In the global context of increasing colonic diseases, colon specific oral drug delivery
systems have shown promise as an effective therapeutic modality. Herein, we developed a …

Colorectal cancer (CRC) is one of the deadliest diseases worldwide due to a lack of early
detection methods and appropriate drug delivery strategies. Conventional imaging …

Currently adopted methods that are used for diagnosis and treatment are not effective in the
successful management of CRC. Nanotechnology has explored a new beginning to the …

Lack of tumor‐infiltration lymphocytes (TILs) and resistances by overexpressed
immunosuppressive cells (principally, myeloid‐derived suppressor cells (MDSCs)) in tumor …

Nanomedicines suffer from poor drug loading and uncontrolled 'burst release'after
administration. Combining prodrug strategies with nanostructured carriers can help to …

Once introduced in the organism, the interaction of nanoparticles with various biomolecules
strongly impacts their fate. Here we show that nanoparticles made of the squalene derivative …